Naloxone
DrugBank ID: DB01183
Summary
| Metric | Value |
|---|---|
| Total Predictions | 50 |
| KG+DL (Dual Validated) | 0 |
| DL Only | 50 |
| KG Only | 0 |
Predictions
| Indication | Score | Source |
|---|---|---|
| opiate dependence | 0.9742 | DL |
| morphine dependence | 0.9669 | DL |
| substance abuse/dependence | 0.9145 | DL |
| continuous spikes and waves during sleep | 0.8817 | DL |
| lissencephaly with cerebellar hypoplasia | 0.8740 | DL |
| progressive encephalopathy with leukodystrophy due to DECR deficiency | 0.8724 | DL |
| schizophreniform disorder | 0.8635 | DL |
| nasal cavity disease | 0.8484 | DL |
| psychotic disorder | 0.8258 | DL |
| hypoglycemia | 0.8153 | DL |
| acute pulmonary heart disease | 0.8087 | DL |
| drug-induced dyskinesia | 0.8064 | DL |
| acute laryngopharyngitis | 0.8062 | DL |
| early-onset familial noncirrhotic portal hypertension | 0.8019 | DL |
| hepatoportal sclerosis | 0.8019 | DL |
| hepatopulmonary syndrome | 0.8019 | DL |
| idiopathic copper-associated cirrhosis | 0.8019 | DL |
| primitive portal vein thrombosis | 0.8019 | DL |
| acute intermittent porphyria | 0.7978 | DL |
| congestive heart failure | 0.7960 | DL |
| pharyngitis | 0.7887 | DL |
| primary hereditary glaucoma | 0.7868 | DL |
| treatment-refractory schizophrenia | 0.7712 | DL |
| open-angle glaucoma | 0.7641 | DL |
| lingual-facial-buccal dyskinesia | 0.7581 | DL |
| chronic tic disorder | 0.7418 | DL |
| early-onset schizophrenia | 0.7398 | DL |
| substance withdrawal syndrome | 0.7373 | DL |
| HIV infectious disease | 0.7283 | DL |
| benign shuddering attacks | 0.7219 | DL |
| extrapyramidal and movement disease | 0.7219 | DL |
| mental disorder | 0.7120 | DL |
| hepatic porphyria | 0.7099 | DL |
| feline acquired immunodeficiency syndrome | 0.7019 | DL |
| simian immunodeficiency virus infection | 0.7019 | DL |
| neurodevelopmental disorder with ataxic gait, absent speech, and decreased cortical white matter | 0.7009 | DL |
| parkinsonian disorder | 0.6919 | DL |
| benign paroxysmal tonic upgaze of childhood with ataxia | 0.6913 | DL |
| psychogenic movement disorders | 0.6884 | DL |
| diaphanospondylodysostosis | 0.6810 | DL |
| primary orthostatic tremor | 0.6756 | DL |
| tremor-nystagmus-duodenal ulcer syndrome | 0.6713 | DL |
| commissural lip fistula | 0.6599 | DL |
| osteoradionecrosis of the mandible | 0.6589 | DL |
| burning mouth syndrome | 0.6550 | DL |
| oral leukoedema | 0.6550 | DL |
| drug/alcohol-induced mental disorder | 0.6381 | DL |
| corneal pigmentation | 0.6379 | DL |
| obsolete rare pulmonary disease | 0.6338 | DL |
| skeletal overgrowth-craniofacial dysmorphism-hyperelastic skin-white matter lesions syndrome | 0.6266 | DL |
External Links
Disclaimer
Predictions are for research purposes only and do not constitute medical advice.
Predictions are for research purposes only and do not constitute medical advice.